Susquehanna Fundamental Investments’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$530K Sell
127,595
-6,867
-5% -$23K 0.01% 1058
2021
Q4
$342K Sell
134,462
-7,833
-6% -$25.8K 0.01% 1075
2021
Q3
$558K Buy
+142,295
New +$711K 0.01% 1144
2021
Q2
Sell
-10,700
Closed -$87K 1816
2021
Q1
$87K Hold
10,700
﹤0.01% 1477
2020
Q4
$90K Hold
10,700
﹤0.01% 1431
2020
Q3
$44K Hold
10,700
﹤0.01% 1325
2020
Q2
$49K Buy
+10,700
New +$49.1K ﹤0.01% 941

Other funds holding GMDA

Susquehanna Fundamental Investments's GMDA Position: Q1 2022 in Review

Susquehanna Fundamental Investments reduced its Gamida Cell Ltd. Ordinary Shares (GMDA) stake by 5.1% in Q1 2022, selling an estimated $23K and leaving 127,595 shares worth $530K. The position accounts for 0.01% of the portfolio, ranked #1058.

Susquehanna Fundamental Investments first reported a position in GMDA in Q2 2020 and has held it in 7 quarters since. The position peaked at $558K in Q3 2021. 59 funds tracked by Wall St. Rank hold GMDA as of Q1 2022.

  • Susquehanna Fundamental Investments held 127,595 shares of Gamida Cell Ltd. Ordinary Shares worth $530K as of Q1 2022.
  • Susquehanna Fundamental Investments sold 6,867 Gamida Cell Ltd. Ordinary Shares shares in Q1 2022, an estimated $23K.
  • Gamida Cell Ltd. Ordinary Shares made up 0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1058 holding.
  • Susquehanna Fundamental Investments first reported a position in Gamida Cell Ltd. Ordinary Shares in Q2 2020 and has held it in 7 quarters since.
  • Susquehanna Fundamental Investments's Gamida Cell Ltd. Ordinary Shares position peaked at $558K in Q3 2021.
  • 59 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.